Jørgensen FS - Search Results

1

Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.

Lund B, Andersen RB, Friis T, Hjorth L, Jørgensen FS, Norman AW, Sørensen OH. Lund B, et al. Among authors: jorgensen fs. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:177s-181s. doi: 10.1111/j.1365-2265.1977.tb03379.x. Clin Endocrinol (Oxf). 1977. PMID: 606415

2

Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.

Sørensen OH, Andersen RB, Christensen MS, Friis T, Hjorth L, Jørgensen FS, Lund B, Melsen F, Mosekilde L. Sørensen OH, et al. Among authors: jorgensen fs. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:169s-175s. doi: 10.1111/j.1365-2265.1977.tb03378.x. Clin Endocrinol (Oxf). 1977. PMID: 342143 Clinical Trial.

3

Letter: Seasonal variations in urinary excretion of calcium.

Transbol I, Jorgensen FS, Lund B, Sorensen OH. Transbol I, et al. Among authors: jorgensen fs. Br Med J. 1975 Mar 29;1(5960):734-5. doi: 10.1136/bmj.1.5960.734-c. Br Med J. 1975. PMID: 1125684 Free PMC article. No abstract available.

4

Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.

Andersen R, Jørgensen FS, Olsen L, Våbenø J, Thorn K, Nielsen CU, Steffansen B. Andersen R, et al. Among authors: jorgensen fs. Pharm Res. 2006 Mar;23(3):483-92. doi: 10.1007/s11095-006-9462-y. Epub 2006 Feb 26. Pharm Res. 2006. PMID: 16489544

5

In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.

Andersen R, Nielsen CU, Begtrup M, Jørgensen FS, Brodin B, Frokjaer S, Steffansen B. Andersen R, et al. Among authors: jorgensen fs. Eur J Pharm Sci. 2006 Jul;28(4):325-35. doi: 10.1016/j.ejps.2006.03.007. Epub 2006 Mar 28. Eur J Pharm Sci. 2006. PMID: 16713701

6

Synthesis and antiangiogenic activity of N-alkylated levamisole derivatives.

Hansen AN, Bendiksen CD, Sylvest L, Friis T, Staerk D, Jørgensen FS, Olsen CA, Houen G. Hansen AN, et al. Among authors: jorgensen fs. PLoS One. 2012;7(9):e45405. doi: 10.1371/journal.pone.0045405. Epub 2012 Sep 14. PLoS One. 2012. PMID: 23024819 Free PMC article.

7

Urinary cyclic AMP. Relation to albumin-corrected serum calcium in healthy persons and patients with primary hyperparathyroidism.

Madsen SN, Badawi I, Jorgensen FS, Skovsted L, Transbol I. Madsen SN, et al. Among authors: jorgensen fs. Acta Med Scand. 1976;200(3):195-9. Acta Med Scand. 1976. PMID: 184691

8

The effect of bendroflumethiazide on total, ultrafiltrable and ionized calcium in serum in normocalcaemic renal stone formers and in hyperparathyroidism.

Jorgensen FS, Transbol I, Binder C. Jorgensen FS, et al. Acta Med Scand. 1973 Oct;194(4):323-6. doi: 10.1111/j.0954-6820.1973.tb19453.x. Acta Med Scand. 1973. PMID: 4749171 No abstract available.

9

The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.

Jorgensen FS, Transbol I. Jorgensen FS, et al. Acta Med Scand. 1973 Oct;194(4):327-34. Acta Med Scand. 1973. PMID: 4749172 No abstract available.

10

Influence of calcium infusion on urinary cyclic AMP and phosphate in hyperparathyroidism.

Børresen T, Jørgensen FS, Transbøl I, Madsen SN. Børresen T, et al. Among authors: jorgensen fs. Acta Med Scand. 1981;210(1-2):15-9. doi: 10.1111/j.0954-6820.1981.tb09769.x. Acta Med Scand. 1981. PMID: 6270986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters